Old API Wind-down Ltd. Share Price

Stocks

ARLZQ

CA03852X1006

Pharmaceuticals

OTC Markets Traded
Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for Old API Wind-down Ltd. -.--% -
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Old API Wind-down Ltd.

Market Cap 87.35T 76.16T 70.54T 66.03T 1L 82.42L 1L 8L 3L 40.57L 3L 3L 1.41Cr P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 25Cr 21Cr 20Cr 19Cr 35Cr 2.32TCr 35Cr 235.41Cr 91Cr 1.14TCr 92Cr 90Cr 3.96TCr EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
+32.62%-5.37%+39.94%+145.38% 98TCr
-3.20%-4.17%+51.52%+39.07% 55TCr
-2.14%-3.68%+16.71%+56.15% 38TCr
-1.75%+0.25%+25.86%+16.53% 32TCr
+0.61%-1.69%+25.42%+13.64% 27TCr
+0.22%-3.10%+24.25%+30.21% 27TCr
+4.59%+1.98%-40.02%-45.89% 19TCr
-1.90%-4.65%+16.56%+47.00% 18TCr
-1.35%-1.68%+14.59%+56.94% 15TCr
Average -0.45%-2.41%+19.43%+39.89% 32.94TCr
Weighted average by Cap. -0.97%-3.38%+28.25%+64.05%

Financials

2016 2017
Net sales 5.43Cr 4.73Cr 4.38Cr 4.1Cr 7.69Cr 512.08Cr 7.74Cr 52Cr 20Cr 252.05Cr 20Cr 20Cr 875.2Cr 11Cr 9.24Cr 8.56Cr 8.01Cr 15Cr 999.69Cr 15Cr 101.49Cr 39Cr 492.06Cr 40Cr 39Cr 1.71TCr
Net income -10Cr -8.98Cr -8.32Cr -7.78Cr -15Cr -971.68Cr -15Cr -99Cr -38Cr -478.27Cr -39Cr -38Cr -1.66TCr -13Cr -11Cr -10Cr -9.46Cr -18Cr -1.18TCr -18Cr -119.94Cr -46Cr -581.51Cr -47Cr -46Cr -2.02TCr
Net Debt 21Cr 18Cr 17Cr 16Cr 30Cr 1.98TCr 30Cr 200.69Cr 78Cr 973Cr 79Cr 77Cr 3.38TCr 25Cr 21Cr 20Cr 19Cr 35Cr 2.32TCr 35Cr 235.33Cr 91Cr 1.14TCr 92Cr 90Cr 3.96TCr
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!